Yuhan
KSC:000100 · KR7000100008
PharmaceuticalsMedium
360
32
Value37
Quality30
Growth51
Safety59
Sentiment54
Value Creation10/20creating some value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
Yuhan clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.
Profile
CountrySouth Korea
IndustryPharmaceuticals
SizeMedium
TypePublic Company
ExchangeKOSE
Employees236
Websiteyuhan.co.kr
ISINKR7000100008
Last UpdateApr 2, 2026
Indices
Themes
DiabetesCardiovascularInfectious DiseasesCentral Nervous SystemNeurologyBiotechnologyPharmaceutical
Description
Analysis
Weak and unloved
Yuhan Corporation is weak and unloved: below-average business metrics and a price that reflects that disappointment.
360° rank · history
1007550250
54
2023202420252026
All-time high
59
Mar 2026
All-time low
19
Jan 2024
Average rank
41
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100